In Conversation

What was the vision behind the creation of the Korea Drug Research Association and its main role in the pharmaceutical sector? Until the middle of…

The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of…

Since KRPIA’s creation in 1999, what would you say have been its main achievements in the South Korean pharmaceutical landscape? KRPIA’s…

You have recently been appointed as General Manager of Servier in South Korea, after coming from several years working in Europe. What perception did…

Cytonet is today Germany’s largest cell therapy enterprise. However, it went through many transformations since its spin-off from Roche Diagnostics…

The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the…

When you became President of Sankyo Pharma Italy in 2003 one of your objectives was to maximize sales of the existing portfolio- and the company's…

You have been in South Korea for several months, following some time as Merck’s President in Pakistan. In your opinion, what do you find as the…

When you were appointed General Director of the Agenzia Italiana del Farmaco (AIFA) in 2007, the dedicated Investigation Commission highlighted the…

Please introduce Handok Pharmaceuticals to our readers, and in particular how it has evolved through partnerships with different multinational…

What is KHIDI’s role in supporting the development of the Korean health industry? KHIDI performs three major roles in supporting the Korean…

Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks…